US

Uwe Schwahn

RP Regeneron Pharmaceuticals: 2 patents #396 of 810Top 50%
SA Sanofi-Aventis: 2 patents #437 of 1,008Top 45%
SB Sanofi Biotechnology: 2 patents #19 of 74Top 30%
AP Aventis Pharmaceuticals: 1 patents #232 of 454Top 55%
SA Sanofi: 1 patents #1,013 of 1,881Top 55%
📍 Frankfurt am Main, DE: #401 of 1,925 inventorsTop 25%
Overall (All Time): #799,370 of 4,157,543Top 20%
6
Patents All Time

Issued Patents All Time

Showing 1–6 of 6 patents

Patent #TitleCo-InventorsDate
12054551 FGFR1/KLB targeting agonistic antigen-binding proteins and conjugates thereof with GLP-1R agonistic peptides Mark Sommerfeld, Thomas LANGER, Werner DITTRICH, Christine RUDOLPH, Matthias Dreyer +3 more 2024-08-06
10995150 Methods for inhibiting atherosclerosis by administering an anti-PCSK9 antibody William J. Sasiela, Viktoria Gusarova, Anusch Peyman, Hans-Ludwig Schafer 2021-05-04
10494442 Methods for inhibiting atherosclerosis by administering an inhibitor of PCSK9 William J. Sasiela, Viktoria Gusarova, Anusch Peyman, Hans-Ludwig Schafer 2019-12-03
8173682 Substituted pyridones as inhibitors of poly(ADP-ribose) polymerase (PARP) Philip M. Weintraub, Paul Robert Eastwood, Shujaath Mehdi, David Stefany, Kwon Yon Musick +5 more 2012-05-08
7863280 Substituted 2-pyridone derivatives, method for their preparation and their use as medicament Stefan Peukert, Stefan Guessregen, Armin Hofmeister, Herman Schreuder 2011-01-04
7795278 Substituted tetrahydro-2H-isoquinolin-1-one derivatives, and methods for the production and use thereof Stefan Peukert, Stefan Guessregen, Armin Hofmeister, Herman Schreuder 2010-09-14